Follow
Uma Devi Ranganathan
Uma Devi Ranganathan
Other namesDevi KRU, Uma Devi K R, Uma Devi K Ranganathan
Scientist F and Head, Department of Immunology, ICMR-National Institute for Research in Tuberculosis
No verified email - Homepage
Title
Cited by
Cited by
Year
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
3472017
Monocyte subsets: phenotypes and function in tuberculosis infection
P Sampath, K Moideen, UD Ranganathan, R Bethunaickan
Frontiers in immunology 9, 340584, 2018
2452018
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020
MV Murhekar, T Bhatnagar, S Selvaraju, K Rade, V Saravanakumar, ...
Indian Journal of Medical Research 152 (1-2), 48-60, 2020
2112020
Immunoglobulin G, A, and M Responses in Serum and Circulating Immune Complexes Elicited by the 16-Kilodalton Antigen of Mycobacterium tuberculosis
A Raja, KR Uma Devi, B Ramalingam, PJ Brennan
Clinical and Vaccine Immunology 9 (2), 308-312, 2002
1102002
Specific and early detection of IgG, IgA and IgM antibodies to Mycobacterium tuberculosis 38kDa antigen in pulmonary tuberculosis
KRU Devi, B Ramalingam, PJ Brennan, PR Narayanan, A Raja
Tuberculosis 81 (3), 249-253, 2001
992001
Improved diagnosis of pulmonary tuberculosis by detection of antibodies against multiple Mycobacterium tuberculosis antigens
A Raja, UD Ranganathan, R Bethunaickan
Diagnostic microbiology and infectious disease 60 (4), 361-368, 2008
622008
A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques
K Jensen, UDK Ranganathan, KKA Van Rompay, DR Canfield, I Khan, ...
Clinical and Vaccine Immunology 19 (8), 1170-1181, 2012
612012
Piloting upfront Xpert MTB/RIF testing on various specimens under programmatic conditions for diagnosis of TB & DR-TB in paediatric population
N Raizada, KS Sachdeva, S Swaminathan, S Kulsange, SD Khaparde, ...
PLoS One 10 (10), e0140375, 2015
512015
Antibody response to Mycobacterium tuberculosis 30 and 16kDa antigens in pulmonary tuberculosis with human immunodeficiency virus coinfection
KRU Devi, B Ramalingam, A Raja
Diagnostic microbiology and infectious disease 46 (3), 205-209, 2003
412003
Role of Alanine Racemase Mutations in Mycobacterium tuberculosisd-Cycloserine Resistance
Y Nakatani, HK Opel-Reading, M Merker, D Machado, S Andres, ...
Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 01575-17, 2017
402017
Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India
A Munir, N Kumar, SB Ramalingam, S Tamilzhalagan, SK Shanmugam, ...
Scientific reports 9 (1), 10283, 2019
382019
Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice
UDK Ranganathan, MH Larsen, J Kim, SA Porcelli, WR Jacobs Jr, ...
Vaccine 28 (1), 152-161, 2009
382009
Purification and characterization of three immunodominant proteins (38, 30, and 16 kDa) of Mycobacterium tuberculosis
KRU Devi, KSS Kumar, B Ramalingam, R Alamelu
Protein Expression and Purification 24 (2), 188-195, 2002
352002
Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India
N Raizada, SD Khaparde, VS Salhotra, R Rao, A Kalra, S Swaminathan, ...
PLoS One 13 (2), e0193194, 2018
342018
Improved diagnosis of pulmonary tuberculosis by detection of free and immune complex-bound anti-30kDa antibodies
A Raja, KRU Devi, B Ramalingam, PJ Brennan
Diagnostic microbiology and infectious disease 50 (4), 253-259, 2004
342004
Isotype-specific anti-38 and 27 kDa (mpt 51) response in pulmonary tuberculosis with human immunodeficiency virus coinfection
B Ramalingam, KRU Devi, A Raja
Scandinavian journal of infectious diseases 35 (4), 234-239, 2003
322003
Monocyte and macrophage miRNA: potent biomarker and target for host-directed therapy for tuberculosis
P Sampath, KM Periyasamy, UD Ranganathan, R Bethunaickan
Frontiers in Immunology 12, 667206, 2021
282021
Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5, 6, 7, 8-tetrahydropyrido [4′, 3′: 4, 5] thieno [2, 3-d] pyrimidin-4 (3H)-one schiff bases
M Narender, K Umasankar, J Malathi, AR Reddy, KR Umadevi, ...
Bioorganic & medicinal chemistry letters 26 (3), 836-840, 2016
282016
Current trends in tuberculosis vaccine
JSV Soundarya, UD Ranganathan, SP Tripathy
medical journal armed forces india 75 (1), 18-24, 2019
232019
Serologic response to a secreted and a cytosolic antigen of Mycobacterium tuberculosis in childhood tuberculosis
A Raja, UD Ranganathan, R Bethunaickan, V Dharmalingam
The Pediatric infectious disease journal 20 (12), 1161-1164, 2001
232001
The system can't perform the operation now. Try again later.
Articles 1–20